Related Experiment Video
Updated: Jan 12, 2026
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
A Case of Large Cell Neuroendocrine Carcinoma of the Bladder With Long-Term Control by Metastasectomy
Naoto Takaoka1, Kosuke Kobayashi1, Takehiro Yamane1
1Department of Urology Tenri Hospital Nara Japan.
Introduction:
Large cell neuroendocrine carcinoma (LCNEC) of the bladder is rare and aggressive. Reports of metastasectomy for single distant metastases are even rarer.
Case Presentation:
A 49-year-old man was admitted to our hospital with gross hematuria. Cystoscopy, magnetic resonance imaging, and computed tomography revealed invasive bladder cancer without metastasis. He underwent transurethral resection of the bladder tumor, and histopathological examination confirmed LCNEC. The patient received neoadjuvant chemotherapy followed by partial cystectomy. Nineteen months postoperatively, a solitary metastasis was detected in the right axillary lymph node, and at 44 months, another solitary metastasis appeared in the subcutaneous tissue outside the right scapula. Both metastases were surgically resected, and no additional treatment was administered. At the time of this writing, there had been no recurrence or metastasis for 42 months following the second metastasectomy.
Conclusion:
Metastasectomy may be an effective treatment option for solitary metastasis of LCNEC of the bladder.
